Tubio, Almera .
HRN: 20-67-13 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2023
CEFUROXIME 1.5GM (VIAL)
08/10/2023
08/16/2023
IVT
1.5g
Q8hrs
Choledocholithiasis
Checking Final Appropriateness
08/10/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/10/2023
08/15/2023
IVT
500mg Vial
Prior To OR Q8hrs
Choledocholithiasis
Checking Final Appropriateness
08/18/2023
CEFUROXIME 1.5GM (VIAL)
08/18/2023
08/25/2023
IV
1.5gms
Q8
Post Operative Antibiotic
Checking Final Appropriateness
08/18/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/18/2023
08/25/2023
IV
500mg
Q8
Intra-abdominal Infection
Checking Final Appropriateness